15 May 2021 : Database Analysis
H Long Terminal Repeat-Associating 2 (HHLA2) is a Biomarker of Advanced Stage Hepatocellular Carcinoma and Promotes Tumor Cell Development In Vitro
Min Luo1ABCE, Yao Xiong2BCE, Yan Lin1CD, Rong Liang1CD, Yongqiang Li1D, Lianying Ge3ADE*DOI: 10.12659/MSM.930215
Med Sci Monit 2021; 27:e930215
Figure 5 Migration and invasion in HepG2 cells after knockdown of HHLA2. (A, B) Light micrographs images from the wound healing assay at 0 and 48 h and quantification of percent migration at 48 h. * P<0.05. (C, D) A transwell migration assay was performed, and cells in the lower chamber were stained with 1% crystal violet and quantified. Three fields were counted per well. ** P<0.01.